Beijing eGOVA Co Future Growth
Future criteria checks 5/6
Beijing eGOVA Co is forecast to grow earnings and revenue by 60.1% and 31% per annum respectively. EPS is expected to grow by 60.1% per annum. Return on equity is forecast to be 4.8% in 3 years.
Key information
60.1%
Earnings growth rate
60.1%
EPS growth rate
IT earnings growth | 33.3% |
Revenue growth rate | 31.0% |
Future return on equity | 4.8% |
Analyst coverage | Low |
Last updated | 04 Sep 2024 |
Recent future growth updates
Recent updates
Revenues Tell The Story For Beijing eGOVA Co,. Ltd (SZSE:300075) As Its Stock Soars 33%
Oct 01One Beijing eGOVA Co,. Ltd (SZSE:300075) Analyst Just Cut Their EPS Forecasts
Sep 05Some Investors May Be Willing To Look Past Beijing eGOVA Co's (SZSE:300075) Soft Earnings
Sep 04These 4 Measures Indicate That Beijing eGOVA Co (SZSE:300075) Is Using Debt Reasonably Well
Aug 08Capital Allocation Trends At Beijing eGOVA Co (SZSE:300075) Aren't Ideal
Jul 15Time To Worry? Analysts Are Downgrading Their Beijing eGOVA Co,. Ltd (SZSE:300075) Outlook
Apr 19Beijing eGOVA Co,. Ltd (SZSE:300075) Stocks Shoot Up 35% But Its P/E Still Looks Reasonable
Mar 06Returns On Capital At Beijing eGOVA Co (SZSE:300075) Paint A Concerning Picture
Feb 28Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 2,004 | 232 | N/A | -103 | 1 |
12/31/2025 | 1,662 | 190 | N/A | -142 | 1 |
12/31/2024 | 1,337 | 151 | N/A | 244 | 1 |
9/30/2024 | 847 | -27 | 61 | 131 | N/A |
6/30/2024 | 1,014 | 66 | 60 | 129 | N/A |
3/31/2024 | 1,235 | 141 | 55 | 114 | N/A |
12/31/2023 | 1,213 | 134 | 72 | 132 | N/A |
9/30/2023 | 1,470 | 259 | 67 | 124 | N/A |
6/30/2023 | 1,553 | 279 | 48 | 102 | N/A |
3/31/2023 | 1,547 | 267 | 38 | 93 | N/A |
1/1/2023 | 1,526 | 255 | 2 | 54 | N/A |
9/30/2022 | 1,612 | 270 | 50 | 96 | N/A |
6/30/2022 | 1,527 | 212 | 6 | 89 | N/A |
3/31/2022 | 1,507 | 218 | 39 | 123 | N/A |
1/1/2022 | 1,481 | 207 | 17 | 102 | N/A |
9/30/2021 | 1,647 | 199 | 48 | 131 | N/A |
6/30/2021 | 1,591 | 197 | 166 | 220 | N/A |
3/31/2021 | 1,455 | 161 | 99 | 149 | N/A |
12/31/2020 | 1,414 | 159 | 180 | 226 | N/A |
9/30/2020 | 1,257 | 109 | 145 | 201 | N/A |
6/30/2020 | 1,223 | 107 | 93 | 142 | N/A |
3/31/2020 | 1,234 | 133 | 168 | 227 | N/A |
12/31/2019 | 1,258 | 131 | 114 | 184 | N/A |
9/30/2019 | 1,423 | 122 | 151 | 206 | N/A |
6/30/2019 | 1,421 | 131 | 190 | 247 | N/A |
3/31/2019 | 1,357 | 122 | 145 | 195 | N/A |
12/31/2018 | 1,289 | 117 | 135 | 176 | N/A |
9/30/2018 | 1,284 | 184 | 36 | 83 | N/A |
6/30/2018 | 1,258 | 187 | N/A | -4 | N/A |
3/31/2018 | 1,228 | 175 | N/A | -45 | N/A |
12/31/2017 | 1,203 | 170 | N/A | -36 | N/A |
9/30/2017 | 1,089 | 151 | N/A | -35 | N/A |
6/30/2017 | 1,044 | 148 | N/A | -42 | N/A |
3/31/2017 | 1,012 | 134 | N/A | -32 | N/A |
12/31/2016 | 967 | 131 | N/A | 23 | N/A |
9/30/2016 | 767 | 135 | N/A | -59 | N/A |
6/30/2016 | 723 | 132 | N/A | 26 | N/A |
3/31/2016 | 664 | 123 | N/A | 79 | N/A |
12/31/2015 | 651 | 121 | N/A | 125 | N/A |
9/30/2015 | 563 | 127 | N/A | 12 | N/A |
6/30/2015 | 555 | 128 | N/A | -20 | N/A |
3/31/2015 | 550 | 120 | N/A | -20 | N/A |
12/31/2014 | 546 | 119 | N/A | -59 | N/A |
9/30/2014 | 498 | 101 | N/A | -11 | N/A |
6/30/2014 | 478 | 100 | N/A | -26 | N/A |
3/31/2014 | 416 | 96 | N/A | -25 | N/A |
12/31/2013 | 406 | 94 | N/A | 14 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 300075 is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.8%).
Earnings vs Market: 300075 is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: 300075 is expected to become profitable in the next 3 years.
Revenue vs Market: 300075's revenue (31% per year) is forecast to grow faster than the CN market (13.9% per year).
High Growth Revenue: 300075's revenue (31% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 300075's Return on Equity is forecast to be low in 3 years time (4.8%).